LOGIN  |  REGISTER
Assertio

Sonida Senior Living to Participate in the BofA Securities 2024 Global Real Estate Conference

September 05, 2024 | Last Trade: US$24.71 0.60 -2.37

DALLAS / Sep 05, 2024 / Business Wire / Sonida Senior Living, Inc. (“Sonida” or the “Company”) (NYSE: SNDA), a leading owner, operator and investor in communities and services for seniors, announced today that Brandon Ribar, President and Chief Executive Officer, and Max Levy, Chief Investment Officer, will participate in the BofA Securities 2024 Global Real Estate Conference on September 12, 2024, at the Bank of America Tower in New York.

Hosted by BofA Global Research, the conference features company roundtable discussions, thematic panel talks with global leaders on emerging trends in the industries and one-on-one/small group meetings with over 140 global issuers.

Management will be available for one-on-one meetings during the conference. To schedule a meeting, please contact your bank representative.

About Sonida

Dallas-based Sonida Senior Living, Inc. is a leading owner, operator and investor in independent living, assisted living and memory care communities and services for senior adults. The Company provides compassionate, resident-centric services and care as well as engaging programming operating 83 senior housing communities in 20 states with an aggregate capacity of approximately 9,000 residents, including 70 communities which the Company owns (including eight communities in which the Company owns varying interests through two separate joint ventures), and 13 communities that the Company manages on behalf of a third-party.

For more information, visit www.sonidaseniorliving.com or connect with the Company on Facebook, X or LinkedIn. 

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page